Europe Medicinal Mushroom Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

What is the Europe Medicinal Mushroom Market Size and Growth Rate?

• The Europe medicinal mushroom market size was valued at USD 34.99 million in 2024 and is expected to reach USD 54.52 million by 2032, at a CAGR of 5.70% during the forecast period
• The essential factors contributing to the growth of the medicinal mushroom market include increasing demand for medicinal mushrooms as investments in public and private healthcare industries, increasing health awareness about the health benefits of medicinal mushrooms among the general population, and continuous launches of supplements of medicinal mushrooms                                                          

What are the Major Takeaways of Medicinal Mushroom Market?

• Growing consumer awareness about the health benefits of medicinal mushrooms, including their potential to boost immunity, manage stress, and provide various nutritional benefits, is a significant driver. The increasing interest in natural and holistic wellness has expanded the market for medicinal mushrooms
• The incorporation of medicinal mushrooms into functional foods, dietary supplements, and nutraceuticals is gaining momentum. Products such as mushroom powders, extracts, capsules, and teas are becoming more popular among health-conscious consumers, contributing to the growth of the market
• U.K. dominated the Europe medicinal mushroom market with the largest revenue share of 40.8% in 2024, driven by increasing demand for plant-based immunity boosters, natural supplements, and functional food ingredients
• Germany is projected to witness fastest growth rate throughout the forecast period, owing to widespread consumer preference for organic, non-GMO, and science-backed health solutions
• The Reishi segment dominated the market with the largest revenue share of 28.9% in 2024, owing to its extensive use in traditional medicine for immune support, anti-inflammatory effects, and stress reduction

Report Scope and Medicinal Mushroom Market Segmentation        

What is the Key Trend in the Medicinal Mushroom Market?

“Functional Wellness and Holistic Nutrition Driving Mainstream Adoption”

• A key trend in the global medicinal mushroom market is the growing consumer shift toward holistic health, immune support, and functional foods. Mushrooms such as Reishi, Lion’s Mane, Chaga, and Cordyceps are gaining popularity due to their adaptogenic and nootropic properties, offering natural solutions for stress, cognition, and immunity
  • For instance, in April 2024, Four Sigmatic expanded its product portfolio with functional coffee infused with Lion’s Mane and Chaga, targeting health-conscious professionals seeking mental clarity and focus
• Product innovation in ready-to-drink beverages, snack bars, and supplement capsules is driving accessibility and consumer acceptance, especially among Millennials and Gen Z. Medicinal mushrooms are also being integrated into skincare products for their antioxidant and anti-inflammatory effects
• In addition, the rise of clean-label and organic wellness trends is boosting demand for non-GMO, gluten-free, and certified organic mushroom-based formulations, aligning with ethical and sustainable consumption patterns
• Companies such as Host Defense and MUD\WTR are investing in traceable sourcing, mycelium biotechnology, and regenerative agriculture to elevate consumer trust and environmental impact
• This trend is expanding the medicinal mushroom market beyond niche users to mainstream health consumers, reinforcing its position in the functional wellness and nutraceutical space

What are the Key Drivers of Medicinal Mushroom Market?

• Increasing consumer awareness about the therapeutic benefits of mushrooms for boosting immunity, reducing inflammation, and improving cognitive function is a primary driver of market growth
  • For instance, in January 2024, Maui Medicinals introduced a range of functional teas with Reishi and Turkey Tail extracts, promoted as daily immunity boosters in response to rising post-pandemic wellness habits
• The expanding trend of natural and plant-based remedies over synthetic pharmaceuticals is also encouraging demand for mushroom-based formulations in dietary supplements, functional foods, and herbal medicine
• Growing scientific validation and clinical studies supporting the efficacy of beta-glucans, triterpenoids, and ergothioneine compounds in mushrooms are encouraging medical professionals and nutraceutical brands to explore commercial applications
• The surge in veganism, clean-label nutrition, and personalized health is accelerating demand for mushroom-infused products, especially among urban consumers with proactive health management goals
• Moreover, government support for functional food R&D and increasing availability of mushroom extracts in powder, capsule, and beverage forms are fostering global market expansion

Which Factor is challenging the Growth of the Medicinal Mushroom Market?

• One of the major challenges in the medicinal mushroom market is the lack of regulatory standardization and clear dosage guidelines across global markets, making it difficult for brands to make health claims or ensure consistent product efficacy
  • For instance, in 2023, several U.S. brands including Life Cykel faced scrutiny over ambiguous labeling and underwhelming active compound levels in mushroom tinctures, leading to consumer distrust
• The variability in active compound concentration due to species differences, growing conditions, and extraction methods makes it difficult to ensure uniform quality and potency, especially for mass production
• In addition, limited consumer education and skepticism around the term “medicinal”—often associated with unverified health claims can hamper adoption, particularly among traditional consumers and healthcare professionals
• High production costs, reliance on organic substrates, and challenges in scaling controlled environment agriculture (CEA) further restrict profit margins and supply chain stability
• Addressing these issues will require transparent labeling, clinical research investment, and enhanced public awareness to solidify medicinal mushrooms as credible components of functional nutrition and preventive healthcare

How is the Medicinal Mushroom Market Segmented?

The market is segmented on the basis of type, product type, form, and therapeutic application.

• By Type

On the basis of type, the medicinal mushroom market is segmented into Reishi, Cordyceps, Chaga, Hericium, and Auricularia. The Reishi segment dominated the market with the largest revenue share of 28.9% in 2024, owing to its extensive use in traditional medicine for immune support, anti-inflammatory effects, and stress reduction. Reishi is widely incorporated in dietary supplements and wellness products across Asia and North America.

The Cordyceps segment is projected to witness the fastest CAGR from 2025 to 2032, driven by rising demand among athletes and aging populations for improved endurance, oxygen utilization, and anti-fatigue benefits.

1. By Product Type

On the basis of product type, the market is segmented into organic and inorganic. The organic segment held the dominant revenue share of 61.5% in 2024, driven by consumer preference for clean-label, chemical-free, and sustainably farmed mushrooms. Certification and traceability have become key differentiators in the medicinal mushroom space, fueling demand for organically produced varieties.

The inorganic segment is expected to grow steadily over the forecast period, mainly due to its affordability and suitability for mass production in functional beverages and supplements.

• By Form

On the basis of form, the market is segmented into powder, tablet, capsules, and tinctures. The powder segment led the market with the largest share of 37.3% in 2024, primarily due to its high versatility and ease of incorporation into smoothies, teas, and food products. Powdered forms also allow for precise dosing and customization in both consumer and clinical settings.

The capsule segment is anticipated to record the highest CAGR from 2025 to 2032, fueled by growing demand for convenient, travel-friendly dosage forms and rising adoption among elderly populations for immune-boosting and anti-inflammatory benefits.

• By Therapeutic Application

On the basis of therapeutic application, the market is segmented into cancer treatment, cardiovascular, physical performance, antioxidant, antiviral, antimicrobial, immunity, gastrointestinal, cholesterol, and others. The immunity segment accounted for the largest market share of 24.6% in 2024, attributed to the post-pandemic health consciousness and preventive healthcare trends. Medicinal mushrooms such as Reishi, Chaga, and Turkey Tail are increasingly recognized for their immune-modulating properties and are widely used in both clinical and at-home wellness solutions.

The cancer treatment segment is projected to witness the fastest CAGR through 2032, driven by research-backed evidence supporting the role of mushrooms in reducing chemotherapy side effects and enhancing overall patient resilience.

Which Region Holds the Largest Share of the Medicinal Mushroom Market?

• U.K. dominated the Europe medicinal mushroom market with the largest revenue share of 40.8% in 2024, driven by increasing demand for plant-based immunity boosters, natural supplements, and functional food ingredients. The region benefits from heightened consumer awareness regarding holistic wellness and natural therapies, particularly in aging populations
• A strong culture of herbal and traditional medicine, combined with robust regulatory support for organic and clean-label products, has propelled the adoption of medicinal mushrooms across food, nutraceutical, and pharmaceutical industries
• The market is further supported by well-developed distribution networks, rising health expenditures, and extensive research initiatives focusing on mushroom-based therapies for chronic diseases and cognitive health

Germany Medicinal Mushroom Market Insight

Germany is projected to witness fastest growth rate throughout the forecast period, owing to widespread consumer preference for organic, non-GMO, and science-backed health solutions. The country has become a hotbed for research on medicinal fungi such as Reishi, Lion’s Mane, and Cordyceps, with applications expanding from traditional medicine into mainstream wellness products. Favorable health insurance policies supporting preventive care and a strong retail infrastructure further enhance accessibility to mushroom-based dietary supplements.

France Medicinal Mushroom Market Insight

France is experiencing steady market expansion, supported by a wellness-conscious population and increasing interest in botanical and fungal therapeutics. The demand for natural immunity boosters, stress-reducing supplements, and functional teas is rising among urban consumers. Domestic wellness brands and pharmacies are increasingly introducing organic mushroom products, while cross-industry collaborations between food, pharma, and wellness firms are pushing product innovation in the premium segment.

Which are the Top Companies in Medicinal Mushroom Market?

The medicinal mushroom industry is primarily led by well-established companies, including:

• Aloha Medicinals Inc (U.S.)
• MycoMedica d.o.o. (Slovenia)
• Mycotrition GmbH (Germany)
• Pilze Wohlrab GmbH & Co. KG (Germany)
• Tyroler Glückspilze (Austria)
• Saint Charles (Austria)
• Myko San (Netherlands)
• Suntory Beverage & Food Asia Pte Ltd (Singapore)
• Nordic Mushrooms (Finland)
• Nyishar (U.K.)

What are the Recent Developments in Europe Medicinal Mushroom Market?

• In October 2021, Aloha Medicinals partnered with Prenexus Health, which is a leading manufacturer of organic prebiotic ingredients for the supplement, to bring the novel mushroom-based prebiotic, MyceliaGI, to market
• In October 2021, Pilze Wohlrab GmbH & Co. KG launched syrup called chaga health at pilze wohlrab. It comes in the usual organic quality and has the healthy elixir of the medicinal mushroom Chaga. It is a booster for health and true support for our immune system
• In May 2021, Nordic Mushrooms won the Start-up Award in the NutraIngredients Awards 2021. NutraIngredients Awards is a respected competition within the nutraceutical and food supplement industry. Thus, the company will create goodwill in the market and will help the market to grow rapidly

SKU-66560